Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

Annals of Internal Medicine

Volumn 134, Issue 5, 2001, Pages 370-379

  Barnett, A H ^a   Bilous, R ^a   Bojestig, M ^a   Crepaldi, G ^a   Nosadini, R ^a   Chaturvedi, N ^a   Fuller, J H ^a   Hardy, R ^a   Stevens, L ^a   Jerums, G ^a   Allen, T ^a   Marre, M ^a   Mathiesen, E ^a   Parving, H H ^a   Mogensen, C E ^a   Poulsen, P L ^a   O'Hare, P ^a   Viberti, G C ^a   Laffel, L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; PERINDOPRIL; RAMIPRIL;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFECT; DRUG INDICATION; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; META ANALYSIS; MICROALBUMINURIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035814977     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-5-200103060-00009     Document Type: Article

References (33)

1. Pathogenesis, prevention, and treatment of diabetic nephropathy
2. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
3. Microalbuminuria is not rare before 5 years of IDDM
4. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with mictoalbuminuria
5. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
6. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
7. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria
8. Guidelines Subcommittee
9. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria
10. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy
11. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure
12. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
13. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria
14. Early ACE-i intervention in microalbuminuria: 24h BP, renal function, and exercise changes
15. ACE-inhibition during two years did not improve U-albumin excretion rate in normotensive microalbuminuric IDDM patients
16. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension
17. The effect of three years of antihypertensive therapy on renal structure in type I diabetic patients with albuminuria
18. Repeated measures in clinical trials: Simple strategies for analysis using summary measures
19. Meta-analysis in clinical trials
20. A general parametric approach to the meta-analysis of randomized clinical trials
21. Meta-analysis using multilevel models with an application to the study of class size effects
22. A bivariate approach to meta-analysis
23. Diabetic nephropathy: Molecular analysis of extracellular matrix and clinical studies update
24. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria
25. Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria
26. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria
27. Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study
28. Effect of angiotensin converting enzyme inhibitor or β blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus
29. Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis
30. Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression